Skip to main content
Top
Published in: BMC Nephrology 1/2021

01-12-2021 | COVID-19 | Research

Experiences of renal healthcare practitioners during the COVID-19 pandemic: a multi-methods approach

Authors: Clare Mc Keaveney, Joanne Reid, Claire Carswell, Ann Bonner, Ilaria de Barbieri, William Johnston, Alexander P. Maxwell, Julien O’Riordan, Veronica Strini, Ian Walsh, Helen Noble

Published in: BMC Nephrology | Issue 1/2021

Login to get access

Abstract

Background

Globally, renal healthcare practitioners provide intensive and protracted support to a highly complex multi-morbid patient population however knowledge about the impact of COVID-19 on these practitioners is extremely limited.

Objective

This study aimed to explore the experiences of COVID-19 with renal healthcare practitioners during the first global lockdown between June 2020 and September 2020.

Methods

A multi-methods approach was carried out including a quantitative survey and qualitative interviews. This was a multinational study of renal healthcare practitioners from 29 countries. Quantitative: A self-designed survey on COVID-19 experiences and standardised questionnaires (General Health Questionnaire-12; Maslach Burnout Inventory). Descriptive statistics were generated for numerical data. Qualitative: Online semi-structured interviews were conducted. Data was subjected to thematic analysis. Renal healthcare practitioners (n = 251) completed an online survey. Thirteen renal healthcare practitioners took part in semi-structured interviews (12 nurses and 1 dietician).

Results

The majority of participants surveyed were female (86.9 %; n = 218), nurses (86.9 %; n = 218) with an average 21.5 (SD = 11.1) years’ experience since professional qualification, and 16.3 years (SD = 9.3) working in renal healthcare. Survey responses indicated a level of preparedness, training and satisfactory personal protective equipment during the pandemic however approximately 40.3 % experienced fear about attending work, and 49.8 % experienced mental health distress. The highest prevalence of burnout was emotional exhaustion (35.9 %). Three themes emerged from the qualitative analysis highlighting the holistic complexities in managing renal healthcare, a neglected specialist workforce, and the need for appropriate support at work during a pandemic.

Conclusions

Results have highlighted the psychological impact, in terms of emotional exhaustion and mental health distress in our sample of renal healthcare practitioners. As the pandemic has continued, it is important to consider the long-term impact on an already stretched workforce including the risk of developing mental health disorders. Future research and interventions are required to understand and improve the provision of psychological support for specialist medical and nursing personnel.
Appendix
Available only for authorised users
Literature
14.
18.
go back to reference Levey AS, Eckardt KU, Dorman NM, Christiansen SL, Cheung M, Jadoul M, et al. Nomenclature for kidney function and disease: Executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Res Clin Pract. 2020;39:151–61. https://doi.org/10.23876/j.krcp.20.393. Levey AS, Eckardt KU, Dorman NM, Christiansen SL, Cheung M, Jadoul M, et al. Nomenclature for kidney function and disease: Executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Res Clin Pract. 2020;39:151–61. https://​doi.​org/​10.​23876/​j.​krcp.​20.​393.
19.
go back to reference Lano G, Braconnier A, Bataille S, Cavaille G, Moussi-Frances J, Gondouin B, et al. Risk factors for severity of COVID-19 in chronic dialysis patients from a multicentre French cohort. Clin Kidney J. 2020;13(5):878–88. https://doi.org/10.1093/ckj/sfaa199. Lano G, Braconnier A, Bataille S, Cavaille G, Moussi-Frances J, Gondouin B, et al. Risk factors for severity of COVID-19 in chronic dialysis patients from a multicentre French cohort. Clin Kidney J. 2020;13(5):878–88. https://​doi.​org/​10.​1093/​ckj/​sfaa199.
21.
go back to reference Maslach C, Jackson SE, Leiter MP. Maslach burnout inventory manual. Palo Alto: Consulting Psychologists; 1996. Maslach C, Jackson SE, Leiter MP. Maslach burnout inventory manual. Palo Alto: Consulting Psychologists; 1996.
22.
go back to reference Goldberg DP. User’s guide to the General Health Questionnaire. Windsor: NFER/Nelson; 1988. Goldberg DP. User’s guide to the General Health Questionnaire. Windsor: NFER/Nelson; 1988.
27.
go back to reference Morse JM, Field PA. Nursing research: The application of qualitative approaches. 2nd ed. Cheltenham: Nelson Thornes; 2002. Morse JM, Field PA. Nursing research: The application of qualitative approaches. 2nd ed. Cheltenham: Nelson Thornes; 2002.
28.
go back to reference Miles MB, Huberman AM. Qualitative data analysis: an expanded sourcebook. 2nd ed. Thousand Oaks: Sage; 1994. Miles MB, Huberman AM. Qualitative data analysis: an expanded sourcebook. 2nd ed. Thousand Oaks: Sage; 1994.
Metadata
Title
Experiences of renal healthcare practitioners during the COVID-19 pandemic: a multi-methods approach
Authors
Clare Mc Keaveney
Joanne Reid
Claire Carswell
Ann Bonner
Ilaria de Barbieri
William Johnston
Alexander P. Maxwell
Julien O’Riordan
Veronica Strini
Ian Walsh
Helen Noble
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2021
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-021-02500-0

Other articles of this Issue 1/2021

BMC Nephrology 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine